I
0.247
0.02 (8.33%)
| Penutupan Terdahulu | 0.228 |
| Buka | 0.232 |
| Jumlah Dagangan | 25,880,000 |
| Purata Dagangan (3B) | 4,309,752 |
| Modal Pasaran | 455,902,720 |
| Harga / Jualan (P/S) | 260.71 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Nov 2024 |
| Margin Operasi (TTM) | 657.78% |
| EPS Cair (TTM) | -0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -18.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -47.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4,140.48% |
| Nisbah Semasa (MRQ) | 0.010 |
| Aliran Tunai Operasi (OCF TTM) | -6.53 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -128.15 M |
| Pulangan Atas Aset (ROA TTM) | -0.67% |
| Pulangan Atas Ekuiti (ROE TTM) | -330.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Specialty Retail (HK) | Bercampur | Bercampur |
| Specialty Retail (Global) | Bercampur | Menurun | |
| Stok | INNOVATIVE PHAR | - | - |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.00 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| INNOVATIVE PHAR | 456 M | - | - | - |
| QIDIAN GUOFENG | 6 B | - | - | 34.17 |
| SA SA INT'L | 2 B | 4.46% | 30.50 | 1.53 |
| GOME RETAIL | 881 M | - | - | 0.210 |
| IH RETAIL | 660 M | 10.43% | 7.67 | 0.750 |
| MI MING MART | 149 M | 8.96% | - | 1.44 |
|
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong. |
|
| Sektor | Consumer Cyclical |
| Industri | Specialty Retail |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 42.28% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |